| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
sodium voltage-gated channel alpha subunit 8 | 0.510 | 0.731 | 1.00 |
|
disease | 0.900 | None | 0.971 | 1 | 0 | 2007 | 2020 | ||||||||
|
calcium voltage-gated channel auxiliary subunit alpha2delta 2 | 0.626 | 0.615 | 1.00 |
|
disease | 0.500 | strong | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
proline rich transmembrane protein 2 | 0.448 | 0.808 | 0.58 |
|
disease | 0.400 | moderate | 0.955 | 1 | 0 | 2012 | 2019 | ||||||||
|
solute carrier family 35 member A2 | 0.525 | 0.808 | 0.72 |
|
disease | 0.340 | strong | 1.000 | 1 | 0 | 2010 | 2019 | ||||||||
|
lysine demethylase 5C | 0.581 | 0.538 | 1.00 |
|
disease | 0.330 | None | 1.000 | 2 | 0 | 2007 | 2016 | ||||||||
|
fibroblast growth factor receptor 3 | 0.391 | 0.846 | 1.6E-05 |
|
disease | 0.320 | moderate | 1.000 | 1 | 0 | 2007 | 2017 | ||||||||
|
protocadherin 12 | 0.722 | 0.346 | 2.9E-13 |
|
disease | 0.310 | None | 1.000 | 4 | 0 | 2008 | 2019 | ||||||||
|
eukaryotic translation initiation factor 2 subunit gamma | 0.604 | 0.731 | 0.96 |
|
disease | 0.310 | strong | 1.000 | 1 | 0 | 2016 | 2017 | ||||||||
|
lectin, mannose binding 2 like | 0.641 | 0.385 | 2.0E-11 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
potassium voltage-gated channel subfamily H member 5 | 0.821 | 0.077 | 2.0E-02 |
|
disease | 0.310 | limited | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
arginyl-tRNA synthetase 2, mitochondrial | 0.663 | 0.462 | 7.7E-14 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2010 | 2019 | ||||||||
|
phosphatidylinositol glycan anchor biosynthesis class H | 0.760 | 0.231 | 0.23 |
|
disease | 0.310 | strong | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
glutamate dehydrogenase 1 | 0.584 | 0.731 | 7.0E-03 |
|
disease | 0.310 | strong | 1.000 | 1 | 0 | 2001 | 2009 | ||||||||
|
zinc finger DHHC-type palmitoyltransferase 9 | 0.670 | 0.577 | 0.74 |
|
disease | 0.310 | strong | 1.000 | 1 | 0 | 2018 | 2019 | ||||||||
|
potassium voltage-gated channel subfamily D member 2 | 0.751 | 0.308 | 1.2E-02 |
|
disease | 0.310 | limited | 1.000 | 1 | 0 | 2014 | 2018 | ||||||||
|
alkylglycerol monooxygenase | 0.780 | 0.423 | 6.8E-26 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2016 | 2019 | ||||||||
|
glutamyl-tRNA synthetase 2, mitochondrial | 0.666 | 0.538 | 1.1E-08 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
phosphatidylinositol glycan anchor biosynthesis class Q | 0.610 | 0.577 | 1.4E-06 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
solute carrier family 5 member 6 | 0.674 | 0.577 | 6.1E-03 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
potassium sodium-activated channel subfamily T member 2 | 0.711 | 0.308 | 4.2E-02 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
eukaryotic translation initiation factor 2A | 0.780 | 0.346 | 6.0E-09 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 | 0.861 | 0.154 | 1.00 |
|
disease | 0.300 | moderate | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
actin gamma 1 | 0.477 | 0.846 | 4.8E-03 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
astrotactin 1 | 0.736 | 0.308 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
SET domain containing 1A, histone lysine methyltransferase | 0.619 | 0.615 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2019 | 2019 |